Bharat Serums and Vaccines Limited Revenue and Competitors

Navi Mumbai,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Bharat Serums and Vaccines Limited's estimated annual revenue is currently $444.6M per year.(i)
  • Bharat Serums and Vaccines Limited's estimated revenue per employee is $201,000

Employee Data

  • Bharat Serums and Vaccines Limited has 2212 Employees.(i)
  • Bharat Serums and Vaccines Limited grew their employee count by 5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

Bharat Serums And Vaccines Limited is one of the fastest growing bio pharmaceutical companies in India. For over 4 decades now, we at Bharat Serums and Vaccines Ltd. (BSVL) have used our scientific resources to develop a range of biological, biotech and pharmaceutical products. Today, as we influence patient outcomes in the therapeutic areas of Women's health and Critical Care and IUI-IVF, we have the privilege of being a partner of choice. BSV's products portfolio includes plasma derivatives, monoclonals, fertility hormones, antifungals, anaesthetics, cardiovascular drugs, and equine immunoglobulin /antitoxins. In addition, BSV offers products in the areas of gynaecology, assisted reproductive technology, critical care, emergency medicine, neurology, nephrology, haematology, and urology. The company provides its products to retail outlets and hospitals through distributors primarily in India, as well as in the Asia Pacific, the Russian Federation, CIS countries, Latin America, Africa. BSV is amongst the top 10 Biotech companies in India. The Company has in its portfolio over 145 brands. The company has over 1000 employees selling its products across the country. Our brands are marketed all over India and exported to over 70 countries across the world We have an open and entrepreneurial culture, with each of our employees taking on significant responsibility in each activity of our value chain, be it in terms of research & development, manufacturing, quality, sales & marketing, distribution, business development or organisation building. Advent International, a global private equity firm has endorsed its faith in our commitment towards bringing life to life

keywords:N/A

N/A

Total Funding

2212

Number of Employees

$444.6M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Bharat Serums and Vaccines Limited's People

NameTitleEmail/Phone
1
Product Executive- Institution BusinessReveal Email/Phone
2
Executive in EngineeringReveal Email/Phone
3
Officer-Research & Development ADL-NDDSReveal Email/Phone
4
Senior Executive - Quality ControlReveal Email/Phone
5
Research ExecutiveReveal Email/Phone
6
Product ExecutiveReveal Email/Phone
7
Quality Assurance Sr. OfficerReveal Email/Phone

Bharat Serums and Vaccines Limited News

2022-04-06 - Bharat Serums and Vaccines to invest Rs 200 crore in Genome Valley

Hyderabad (Telangana) [India], April 12 (ANI): Biopharmaceutical firm Bharat Serums and Vaccines Limited (BSV) on Tuesday said it would...

2022-04-06 - Bharat Serums to invest Rs 200 crore in Genome Valley

HYDERABAD: Cementing Hyderabad's position in life sciences & vaccines, Bharat Serums and Vaccines Limited (BSV) has announced Rs 200 crore...

2022-04-06 - Bharat Serums and Vaccines to invest ?200 crore in Genome Valley

Bharat Serums and Vaccines Limited (BSV) has announced an investment of ?200 crore in the state-of-the-art injectable and vaccine...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A2353-7%N/A
#2
N/A245912%N/A
#3
N/A27756%N/A
#4
$300M29815%N/A
#5
$317.4M323912%N/A

Bharat Serums and Vaccines Limited Executives


NameTitle
Pragati MaheshwariFinancial Transformation Projects & Audits, Office of CFO
Chetan SinghAssistant Vice President Sales
Cesar BartensVice President - Cluster Head Latam